A SINGLE-ARM, MULTICENTER PHASE IIIB CLINICAL TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF PROPHYLACTIC EMICIZUMAB IN HEMOPHILIA A PATIENTS WITH INHIBITORS

drug protocol number
MO39129
drug sponsor
Roche
drug study
Emicizumab
drug trial site
KFSH & RC-R
drug status
Completed
drug phase